Derived from rosaceous plant seed, amygdalin belongs to aromatic cyanogenic glycoside group, and its anticancer effects have been supported by mounting evidence. In this study, we objected to investigate amygdalin effect on two antiapoptotic genes (Survivin, XIAP) and two lncRNAs (GAS5, MALAT1) in human cancer cells (A549, MCF7, AGS). Employing RT-qPCR analysis, we compared the mRNA levels of the genes related to apoptosis in A549, MCF7, and AGS cancer cells between amygdalin-treated (24, 48 and 72 h) and un-treated groups. RNA was extracted from both cell groups and then cDNAs were synthesized. The changes in the gene expression levels were specified using ΔΔCt method. RT-qPCR analysis has revealed that the expression of Survivin, XIAP, GAS5 and MALAT1 in amygdala-treated cancer cells were significantly different, compared to the un-treated cells. However, these expressions were different depending on the treatment time. According to the results, amygdalin significantly inhibited the expression level of Survivin, and XIAP genes in treated via untreated group. Our findings suggest that amygdalin might have an anticancer effect due to the various gene expressions in A549, MCF7, and AGS human cancer cells, showing it’s potential as a natural therapeutic anticancer drug.
Amygdalin Antiapoptotic genes LncRNAs Cancer cell line
This is a preview of subscription content, log in to check access.
Iran’s National Elites Foundation give this opportunity to graduate students to work on a scientific project instead of going to the military garrison. This manuscript is an outcome of military service project of first author (Mr. Asghar Arshi). Also, the authors would like to thank all the staff members of the Cellular and Molecular Research Center, Shahrekord University of Medical Sciences in Iran for their sincere support.
AA and SMH: Conceptualization; FH: Software; ZYA: Validation; FSH and ML: Formal analysis; SMH: Investigation; HK and MSD: Resources; AA and SMH: Writing-original draft preparation, Writing-review & editing; SMH: Supervision.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
This article does not contain any studies with human participants performed by any of the authors.
Milazzo S, Ernst E, Lejeune S et al (2011) Laetrile treatment for cancer. In: Milazzo S (ed) Cochrane database of systematic reviews. Wiley, Chichester, p CD005476Google Scholar
Isoza T, Matano Y, Yamamoto K et al (2001) Quantitative determination of amygdalin epimers by cyclodextrin-modified micellar electrokinetic chromatography. J Chromatogr A 923:249–254CrossRefGoogle Scholar
Jaswal V, Palanivelu J, C R (2018) Effects of the Gut microbiota on amygdalin and its use as an anti-cancer therapy: substantial review on the key components involved in altering dose efficacy and toxicity. Biochem Biophys Rep 14:125–132. https://doi.org/10.1016/j.bbrep.2018.04.008Google Scholar
Chang H-K, Shin M-S, Yang H-Y et al (2006) Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biol Pharm Bull 29:1597–1602CrossRefGoogle Scholar
Sarela AI, Scott N, Ramsdale J et al (2001) Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 8:305–310CrossRefGoogle Scholar
Karnoub AE, Weinberg RA (2006) Chemokine networks and breast cancer metastasis. Breast Dis 26:75–85CrossRefGoogle Scholar
Smith CM, Steitz JA (1998) Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol 18:6897–6909CrossRefGoogle Scholar
Wang H, Khor TO, Shu L et al (2012) Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med Chem 12:1281–1305CrossRefGoogle Scholar